Willma E Polgar

Title: Willma E Polgar: Innovator in Nicotinic Acetylcholine Receptor Modulation

Introduction

Willma E Polgar is a notable inventor based in Sunnyvale, CA (US). He has made significant contributions to the field of pharmacology, particularly in the modulation of nicotinic acetylcholine receptors. His work has implications for treating various medical conditions, showcasing the potential of his innovations.

Latest Patents

Willma E Polgar holds a patent for "Nicotinic acetylcholine receptor modulators." This patent describes compounds that can selectively or non-selectively modulate nicotinic acetylcholine receptors. The compounds, compositions, and methods outlined in the patent are useful for treating patients suffering from conditions such as pain, chemical addictions, Parkinson's disease, Alzheimer's disease, and other neurodegenerative disorders. Notably, the compounds include a 7- to 11-membered azabicyclo ring, which is a key feature of his invention.

Career Highlights

Willma E Polgar is associated with SRI International, a renowned research institute known for its innovative contributions to science and technology. His work at SRI International has allowed him to explore and develop groundbreaking solutions in the medical field.

Collaborations

Throughout his career, Willma has collaborated with talented individuals such as Faming Jiang and Taline Khroyan. These collaborations have enriched his research and contributed to the advancement of his projects.

Conclusion

Willma E Polgar's innovative work in nicotinic acetylcholine receptor modulation highlights his significant contributions to medical science. His patent and collaborations reflect a commitment to addressing critical health challenges through scientific innovation.